KR20230152972A - Functional cosmetic composition containing EGF as an active ingredient - Google Patents
Functional cosmetic composition containing EGF as an active ingredient Download PDFInfo
- Publication number
- KR20230152972A KR20230152972A KR1020220052581A KR20220052581A KR20230152972A KR 20230152972 A KR20230152972 A KR 20230152972A KR 1020220052581 A KR1020220052581 A KR 1020220052581A KR 20220052581 A KR20220052581 A KR 20220052581A KR 20230152972 A KR20230152972 A KR 20230152972A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- skin
- egf
- hgh
- cosmetic composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 106
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 239000004480 active ingredient Substances 0.000 title claims abstract description 9
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims abstract description 55
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims abstract description 53
- 101800003838 Epidermal growth factor Proteins 0.000 claims abstract description 53
- 229940116977 epidermal growth factor Drugs 0.000 claims abstract description 53
- 230000006872 improvement Effects 0.000 claims abstract description 37
- 241001480003 Chaetothyriales Species 0.000 claims abstract description 17
- 239000000419 plant extract Substances 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims description 98
- 244000215747 Pachyrhizus erosus Species 0.000 claims description 20
- 235000001591 Pachyrhizus erosus Nutrition 0.000 claims description 20
- 235000018669 Pachyrhizus tuberosus Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 229940059402 eriobotrya japonica leaf extract Drugs 0.000 claims description 4
- 229940056278 impatiens balsamina flower extract Drugs 0.000 claims description 4
- 229940083407 lepidium meyenii root extract Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229940074113 rosa multiflora fruit extract Drugs 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract description 43
- 102000002265 Human Growth Hormone Human genes 0.000 abstract description 43
- 108010000521 Human Growth Hormone Proteins 0.000 abstract description 43
- 230000037303 wrinkles Effects 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 18
- 238000000855 fermentation Methods 0.000 abstract description 11
- 230000004151 fermentation Effects 0.000 abstract description 11
- 230000008591 skin barrier function Effects 0.000 abstract description 7
- 230000002500 effect on skin Effects 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 description 29
- 239000006071 cream Substances 0.000 description 25
- 240000000759 Lepidium meyenii Species 0.000 description 22
- 235000000421 Lepidium meyenii Nutrition 0.000 description 22
- 206010040954 Skin wrinkling Diseases 0.000 description 22
- 235000012902 lepidium meyenii Nutrition 0.000 description 22
- 241001495448 Impatiens <genus> Species 0.000 description 19
- 229930190166 impatien Natural products 0.000 description 19
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 18
- 241001092070 Eriobotrya Species 0.000 description 17
- 241000109365 Rosa arkansana Species 0.000 description 17
- 235000005066 Rosa arkansana Nutrition 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 16
- 238000002156 mixing Methods 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 238000000605 extraction Methods 0.000 description 11
- -1 skin protection Chemical compound 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 4
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960003471 retinol Drugs 0.000 description 4
- 235000020944 retinol Nutrition 0.000 description 4
- 239000011607 retinol Substances 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000018716 Impatiens biflora Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000287181 Sturnus vulgaris Species 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- 235000007173 Abies balsamea Nutrition 0.000 description 2
- 239000004857 Balsam Substances 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000204852 Aureobasidium melanogenum Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102100034629 Hemopexin Human genes 0.000 description 1
- 108010026027 Hemopexin Proteins 0.000 description 1
- 235000015912 Impatiens biflora Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010081750 Reticulin Proteins 0.000 description 1
- 244000050053 Rosa multiflora Species 0.000 description 1
- 235000000656 Rosa multiflora Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- NEMFQSKAPLGFIP-UHFFFAOYSA-N magnesiosodium Chemical compound [Na].[Mg] NEMFQSKAPLGFIP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 EGF(Epidermal Growth Factor) 및 hGH(human growth hormone)를 유효성분으로 함유하는 피부개선용 화장료 조성물에 관한 것으로, 구체적으로 본 발명의 EGF 및 hGH를 필수적으로 포함하는 조성물이 주름 개선, 탄력증진 효과를 포함하는 피부 개선에 유의적인 효과를 나타냄을 확인하였으며, 상기 EGF 및 hGH와 식물추출물, 흑효모 발효물을 포함하는 조성물은 피부보호, 피부장벽 개선, 탄력증진, 주름 관리, 광채부여를 포함하는 피부 개선용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있다.The present invention relates to a cosmetic composition for skin improvement containing EGF (Epidermal Growth Factor) and hGH (human growth hormone) as active ingredients. Specifically, the composition essentially containing EGF and hGH of the present invention improves wrinkles and improves elasticity. It was confirmed that it has a significant effect on skin improvement, including an enhancement effect, and the composition containing EGF and hGH, plant extracts, and black yeast fermentation protects the skin, improves the skin barrier, improves elasticity, manages wrinkles, and imparts radiance. It can be usefully used as an active ingredient in a cosmetic composition for improving skin containing it.
Description
본 발명은 EGF(Epidermal Growth Factor)를 고 함량으로 함유하는 피부보호, 피부장벽 개선, 탄력증진, 주름 관리, 광채부여를 포함하는 피부 개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for skin improvement containing a high content of EGF (Epidermal Growth Factor) for skin protection, skin barrier improvement, elasticity enhancement, wrinkle management, and radiance.
피부는 외부 환경으로부터 인체를 보호하며, 내부의 수분 및 유용 성분이 밖으로 유출되는 것을 막아주는 장벽기능, 체온조절, 배설 등 다양한 생리적 기능을 담당하고 있는 중요한 기관이다. The skin is an important organ that protects the human body from the external environment and is responsible for various physiological functions such as barrier function that prevents internal moisture and useful ingredients from leaking out, body temperature regulation, and excretion.
그러나, 일반적으로 나이가 들면서 이러한 기능들이 점차 약화되고 피부의 노화가 진행된다. 특히, 피부 장벽의 기능을 수행하는 지질층의 지질 조성과 함량이 변화하면서 그 기능이 급격히 저하되는데, 피부 수분 함량이 감소하게 되면, 피부가 건조해지고, 주름이 형성되며, 기미, 주근깨, 색소 침착 및 다양한 피부 병변이 유발된다.However, in general, as we age, these functions gradually weaken and skin aging progresses. In particular, as the lipid composition and content of the lipid layer that performs the function of the skin barrier changes, its function rapidly deteriorates. When the skin moisture content decreases, the skin becomes dry, wrinkles form, spots, freckles, pigmentation, and A variety of skin lesions are caused.
피부 주름 형성에 관련이 있는 결합 조직은 주로 콜라겐 섬유(collagen fiber), 세망섬유(reticular fiber), 엘라스틴 섬유(elastic fiber) 등의 섬유 성분으로 구성되어 있다. Connective tissue, which is involved in the formation of skin wrinkles, is mainly composed of fibrous components such as collagen fibers, reticular fibers, and elastin fibers.
진피 조직 내에 있는 콜라겐과 엘라스틴을 분해하는 MMP-1은 MMP(matrix metalloproteinase) 중 하나의 종류로서 피부 내에 존재하는 단백질 분해효소이며, 세포 간 형태 형성, 상처 치유, 조직 재생 및 재조직에 중요한 단백질이다. MMP-1, which decomposes collagen and elastin in dermal tissue, is a type of MMP (matrix metalloproteinase), a proteolytic enzyme present in the skin, and is an important protein in intercellular morphogenesis, wound healing, tissue regeneration, and reorganization.
그러나, MMP-1은 자외선에 노출되었을 때, 체내에서 평소보다 많이 생성되어, 콜라겐과 결합한 후, 콜라겐을 절단하여 피부 노화를 유발하게 된다. 보다 구체적으로, 콜라겐 단백질들은 'MMP-1 헤모펙신 도메인(hemopexin domain)'에 특이적으로 결합한다. 이로 인해, 콜라겐의 3차 구조를 풀게 되고, MMP-1 촉매활성 도메인(catalytic domain)의 아연이온과 결합 후, 절단되어진다. However, when exposed to ultraviolet rays, MMP-1 is produced in greater quantities than usual in the body, binds to collagen, and then cuts collagen, causing skin aging. More specifically, collagen proteins specifically bind to the 'MMP-1 hemopexin domain'. As a result, the tertiary structure of collagen is solved, and after binding to the zinc ion of the catalytic domain of MMP-1, it is cleaved.
이러한 과정을 통해 주름 발생 등의 피부 노화가 진행되는데, 최근 외모에 대한 관심이 높아지면서, 피부노화를 지연시키고 예방하기 위한 연구가 진행되고 있다. 또한, 탄력 있는 피부를 유지 및 개선하기 위해 화장품에 대한 관심도 높아지고 있는 실정이다.Through this process, skin aging, including the development of wrinkles, progresses. Recently, as interest in appearance has increased, research is being conducted to delay and prevent skin aging. In addition, interest in cosmetics to maintain and improve elastic skin is increasing.
이러한, 피부 주름을 개선 시키기 위해 가장 많이 사용되는 것으로는 레티놀 (retinol)이 있다. 레티놀(retinol)은 주름 기능성 식약처 고시형 원료로써 표피세포의 분화 및 재생을 조절한다고 알려져 있다(Griffiths CE et al., The New England Jornal of Medicine. 329(8):530-535). 그러나, 레티놀의 경우, 효과는 우수하지만 열 안정성이 낮아 열을 가했을 때 변형이 쉽고, 독성이 높아 피부자극을 유발하는 문제가 있다. 레티놀의 불안정성을 해결하기 위해, 최근에는 'ECM(Extra-Cellular Matrix)' 조절 성분으로 작약에서 추출한 파에오니플로린(paeoniflorin), 인삼 내에 존재하는 컴파운드 K(compound K) 등 다양한 천연 물질들이 피부 주름 개선 소재로 사용되고 있다. The most commonly used drug to improve skin wrinkles is retinol. Retinol, a functional ingredient for wrinkles notified by the Ministry of Food and Drug Safety, is known to regulate differentiation and regeneration of epidermal cells (Griffiths CE et al., The New England Jornal of Medicine. 329(8):530-535). However, in the case of retinol, although it is effective, it has low thermal stability, so it is easily deformed when heat is applied, and has high toxicity, causing skin irritation. To solve the instability of retinol, various natural substances such as paeoniflorin extracted from peony and compound K present in ginseng have recently been used as 'ECM (Extra-Cellular Matrix)' regulating ingredients to improve skin wrinkles. It is used as a material.
이에, 본 발명자들은 피부개선용 화장료를 개발하기 위해 노력한 결과, EGF(Epidermal Growth Factor) 및 hGH(human growth hormone)를 필수적으로 포함하는 조성물은 주름 개선, 탄력증진 효과를 포함하는 피부 개선에 유의적인 효과를 나타냄을 확인하였으며, 상기 EGF 및 hGH를 피부개선용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있음을 밝힘으로써, 본 발명을 완성하였다.Accordingly, the present inventors made efforts to develop cosmetics for skin improvement, and as a result, a composition essentially containing EGF (Epidermal Growth Factor) and hGH (human growth hormone) was found to have significant skin improvement effects, including wrinkle improvement and elasticity enhancement effects. It was confirmed that the results were effective, and the present invention was completed by revealing that EGF and hGH can be effectively used as active ingredients in cosmetic compositions for skin improvement.
본 발명의 목적은 EGF(Epidermal Growth Factor) 및 hGH(human growth hormone)를 고 함량으로 함유하는 피부보호, 피부장벽 개선, 탄력증진, 주름 관리, 광채부여를 포함하는 피부 개선용 화장료 조성물을 제공하기 위한 것이다.The purpose of the present invention is to provide a cosmetic composition for skin improvement containing a high content of EGF (Epidermal Growth Factor) and hGH (human growth hormone), including skin protection, skin barrier improvement, elasticity promotion, wrinkle management, and radiance imparting. It is for.
상기 목적을 달성하기 위하여, 본 발명은 EGF(Epidermal Growth Factor) 및 hGH(human growth hormone)를 유효성분으로 함유하는 피부 개선용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition for improving skin containing EGF (Epidermal Growth Factor) and hGH (human growth hormone) as active ingredients.
아울러, 본 발명은 봉선화 꽃 추출물(Impatiens balsamina Flower Extract), 찔레꽃 추출물(Rosa multiflora Fruit Extract), 마카뿌리 추출물(Lepidium meyenii Root Extract), 비파나무 잎 추출물(Eriobotrya japonica Leaf Extract) 및 히카마 뿌리 추출물(Pachyrhizus erosus Root Extract)로 구성된 군으로부터 선택되는 어느 하나 이상, 및 흑효모 추출물을 추가로 포함하는 피부 개선용 화장료 조성물을 제공한다.In addition, the present invention includes Impatiens balsamina Flower Extract, Rosa multiflora Fruit Extract, Lepidium meyenii Root Extract, Eriobotrya japonica Leaf Extract, and Jicama Root Extract ( Provided is a cosmetic composition for improving skin, further comprising at least one selected from the group consisting of Pachyrhizus erosus Root Extract, and black yeast extract.
본 발명의 EGF(Epidermal Growth Factor) 및 hGH(human growth hormone)를 필수적으로 포함하는 조성물은 주름 개선, 탄력증진 효과를 포함하는 피부 개선에 유의적인 효과를 나타냄을 확인함으로써, 상기 EGF 및 hGH와 식물추출물, 흑효모 발효물을 포함하는 조성물은 피부보호, 피부장벽 개선, 탄력증진, 주름 관리, 광채부여를 포함하는 피부 개선용 화장료 조성물에 유효성분으로 유용하게 사용될 수 있다.By confirming that the composition essentially containing EGF (Epidermal Growth Factor) and hGH (human growth hormone) of the present invention has a significant effect on skin improvement, including wrinkle improvement and elasticity enhancement effects, it was confirmed that the EGF and hGH and plant Compositions containing extracts and fermented black yeast can be usefully used as active ingredients in cosmetic compositions for skin improvement, including skin protection, skin barrier improvement, elasticity enhancement, wrinkle management, and radiance imparting.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 EGF(Epidermal Growth Factor) 및 hGH(human growth hormone)를 유효성분으로 함유하는 피부 개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for improving skin containing EGF (Epidermal Growth Factor) and hGH (human growth hormone) as active ingredients.
상기 EGF 또는 hGH는 시판되는 것, 제조한 것 어느 것을 모두 사용할 수 있으며, 상기 hGH는 하기와 같이 제조되는 것이 바람직하나 이에 한정되지 않는다:The EGF or hGH can be either commercially available or manufactured, and the hGH is preferably prepared as follows, but is not limited thereto:
1) 대장균을 이용하여 LB 배지에서 12시간 이상 종배양 후, 본 배양 10시간을 거쳐 유가식 배양을 통해 hGH를 생산하는 발효 배양 단계;1) Fermentation culture step of producing hGH through fed-batch culture using E. coli after seed culture in LB medium for more than 12 hours, followed by main culture for 10 hours;
2) 발효배양 후 OD 140 이상이 되면 균체를 회수하기 위하여 연속원심분리기를 이용하여 배양액과 균체를 분리하여 회수하는 단계;2) After fermentation culture, when the OD reaches 140 or higher, separate and recover the culture medium and the cells using a continuous centrifuge to recover the cells;
3) 균체 안에 발현된 hGH를 얻어내기 위하여 고압력세포파쇄기를 이용하여 균체를 파쇄하여 hGH를 용출시키는 세포 파세 단계;3) a cell crushing step in which the cells are disrupted using a high-pressure cell disruptor to elute hGH in order to obtain hGH expressed in the cells;
4) 순수한 hGH를 얻어내기 위하여 양이온 및 음이온 크로마토그래피 정제법을 사용하여 정제한 후 순도 95% 이상의 hGH를 수득하는 단계; 및4) purifying hGH using cation and anion chromatography purification to obtain pure hGH, and then obtaining hGH with a purity of 95% or more; and
5) 순도 95% 이상의 hGH를 원하는 농도로 농축시킨 후 안정성을 높이기 위해 최종버퍼로 교환하여 보관하는 단계.5) Step of concentrating hGH with a purity of 95% or higher to the desired concentration and then exchanging it with a final buffer and storing it to increase stability.
한편, 본 발명의 EGF 또는 hGH는 고 함량으로 포함되는 것이 바람직하고, 바람직하게는 EGF는 조성물 전체 중량에 대하여 0.5 내지 2 ppm 함유되는 것이 바람직하고, hGH는 조성물 전체 중량에 대하여 5 내지 15 ppm 함유되는 것이 바람직하다.Meanwhile, the EGF or hGH of the present invention is preferably contained in a high content, preferably EGF is contained at 0.5 to 2 ppm based on the total weight of the composition, and hGH is contained at 5 to 15 ppm based on the total weight of the composition. It is desirable to be
또한, 본 발명의 화장료 조성물은 식물 추출물 및 흑효모 발효물을 추가로 포함하는 것이 바람직하고, 상기 식물 추출물은 봉선화 꽃 추출물(Impatiens balsamina Flower Extract), 찔레꽃 추출물(Rosa multiflora Fruit Extract), 마카뿌리 추출물(Lepidium meyenii Root Extract), 비파나무 잎 추출물(Eriobotrya japonica Leaf Extract) 및 히카마 뿌리 추출물(Pachyrhizus erosus Root Extract)로 구성된 군으로부터 선택되는 어느 하나 이상인 것이 보다 바람직하고, 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물 및 히카마 뿌리 추출물로 이루어진 식물 추출물을 사용하는 것이 보다 바람직하다.In addition, the cosmetic composition of the present invention preferably further includes a plant extract and a fermented black yeast, and the plant extract includes Impatiens balsamina Flower Extract, Rosa multiflora Fruit Extract, and Maca Root Extract. ( Lepidium meyenii Root Extract), loquat leaf extract ( Eriobotrya japonica Leaf Extract), and jicama root extract ( Pachyrhizus erosus Root Extract). More preferably, it is at least one selected from the group consisting of impatiens flower extract, wild rose extract, and maca. It is more preferable to use plant extracts consisting of root extract, loquat leaf extract and jicama root extract.
상기 식물 추출물은 하기의 단계들을 포함하는 방법에 의해 제조되는 것이 바람직하나, 이에 한정되지 않는다: The plant extract is preferably prepared by a method comprising the following steps, but is not limited thereto:
1) 시료에 추출용매를 가하여 추출하는 단계;1) Extracting by adding an extraction solvent to the sample;
2) 단계 1)의 추출물을 여과하는 단계;2) filtering the extract of step 1);
3) 단계 2)의 여과물을 감압 농축하는 단계; 및3) Concentrating the filtrate of step 2) under reduced pressure; and
4) 단계 3)의 농축물을 건조하는 단계.4) Drying the concentrate of step 3).
본 발명의 제조방법에 있어서, 단계 1)의 식물 시료는 재배한 것 또는 시판되는 것을 제한 없이 사용할 수 있다. In the production method of the present invention, the plant sample in step 1) can be used without limitation, either cultivated or commercially available.
본 발명의 제조방법에 있어서, 상기 단계 1)의 추출용매는 물, 알코올 또는 이의 혼합물을 사용하는 것이 바람직하다. 상기 알코올로는 C1 내지 C2의 저급 알코올 이용하는 것이 바람직하며, 저급 알코올로는 에탄올 또는 메탄올을 이용하는 것이 바람직하다. 추출방법으로는 진탕추출, Soxhelt 추출 또는 환류 추출을 이용하는 것이 바람직하나, 이에 한정하지 않는다. 상기 추출용매를 건조된 국화 분량의 1 내지 10배 첨가하여 추출하는 것이 바람직하며, 2 내지 3배 첨가하여 추출하는 것이 더욱 바람직하다. 추출 온도는 20℃ 내지 100℃인 것이 바람직하며, 80℃ 내지 100℃인 것이 가장 바람직하나, 이에 한정하지 않는다. 또한, 추출시간은 1 내지 48시간이 바람직하며, 2 내지 10시간이 더욱 바람직하고, 2 내지 5시간이 가장 바람직하나, 이에 한정하지 않는다. 아울러 추출 횟수는 1 내지 5회인 것이 바람직하며, 3 내지 4회 반복 추출하는 것이 더욱 바람직하고, 3회인 것이 가장 바람직하나, 이에 한정되는 것은 아니다. In the production method of the present invention, it is preferable to use water, alcohol, or a mixture thereof as the extraction solvent in step 1). The alcohol is preferably a C 1 to C 2 lower alcohol, and the lower alcohol is preferably ethanol or methanol. The extraction method is preferably shaken extraction, Soxhelt extraction, or reflux extraction, but is not limited thereto. It is preferable to extract by adding 1 to 10 times the amount of the extraction solvent as the dried chrysanthemum, and more preferably to extract by adding 2 to 3 times the amount of the dried chrysanthemum. The extraction temperature is preferably 20°C to 100°C, and most preferably 80°C to 100°C, but is not limited thereto. In addition, the extraction time is preferably 1 to 48 hours, more preferably 2 to 10 hours, and most preferably 2 to 5 hours, but is not limited thereto. In addition, the number of extractions is preferably 1 to 5 times, more preferably 3 to 4 times, and most preferably 3 times, but is not limited thereto.
본 발명의 제조방법에 있어서, 단계 3)의 감압농축은 진공 감압 농축기 또는 진공회전증발기를 이용하는 것이 바람직하나 이에 한정하지 않는다. 또한, 건조는 감압건조, 진공건조, 비등건조, 분무건조 또는 동결건조하는 것이 바람직하나 이에 한정하지 않는다. In the production method of the present invention, the vacuum concentration in step 3) is preferably performed using a vacuum vacuum concentrator or a vacuum rotary evaporator, but is not limited thereto. In addition, drying is preferably performed by reduced pressure drying, vacuum drying, boiling drying, spray drying, or freeze drying, but is not limited thereto.
또한, 본 발명의 식물 추출물 및 흑효모 발효물은 조성물 전체 중량에 대하여 0.02 내지 0.05 중량부 첨가되는 것이 바람직하나 이에 한정되지 않는다.In addition, the plant extract and fermented black yeast of the present invention are preferably added in an amount of 0.02 to 0.05 parts by weight based on the total weight of the composition, but are not limited thereto.
또한, 본 발명의 피부 개선 효과는 피부보호, 피부장벽 개선, 탄력증진, 주름개선 및 광채부여로 이루어진 군으로부터 선택되는 어느 하나 이상의 효과일 수 있다. In addition, the skin improvement effect of the present invention may be any one or more effects selected from the group consisting of skin protection, skin barrier improvement, elasticity improvement, wrinkle improvement, and radiance.
본 발명의 구체적인 실시예에서, 본 발명자들은 다양한 식물 조합, EGF(Epidermal Growth Factor) 및/또는 hGH(human growth hormone)를 포함하는 크림 제형을 제조한 후, 30세 이후의 여성을 대상으로 주름 개선 및 탄력 증진 효과를 확인한 결과, 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물, 흑효모 발효물, EGF 및 hGH를 필수적으로 포함하는 혼합물은 성분들의 상호작용을 통해 빠른 시간 내에 현저한 주름 개선 및 탄력 증진 효과를 나타냄을 확인하였다(표 3 참조).In a specific embodiment of the present invention, the present inventors prepared a cream formulation containing various plant combinations, Epidermal Growth Factor (EGF), and/or human growth hormone (hGH), and then used it to improve wrinkles in women over the age of 30. As a result of confirming the effect of improving elasticity, the mixture essentially containing impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, jicama root extract, fermented black yeast, EGF, and hGH was obtained through the interaction of the ingredients. It was confirmed that it showed significant wrinkle improvement and elasticity improvement effects within a short period of time (see Table 3).
따라서, 본 발명의 EGF(Epidermal Growth Factor) 및 hGH(human growth hormone)를 필수적으로 포함하는 조성물은 주름 개선, 탄력증진 효과를 포함하는 피부 개선에 유의적인 효과를 나타내며, 따라서, 상기 EGF 및 hGH와 식물추출물, 흑효모 발효물을 포함하는 조성물은 피부보호, 피부장벽 개선, 탄력증진, 주름 관리, 광채부여를 포함하는 피부 개선용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있다.Therefore, the composition essentially containing EGF (Epidermal Growth Factor) and hGH (human growth hormone) of the present invention exhibits significant effects on skin improvement, including wrinkle improvement and elasticity enhancement effects, and therefore, the EGF and hGH Compositions containing plant extracts and fermented black yeast can be useful as active ingredients in cosmetic compositions for skin improvement, including skin protection, skin barrier improvement, elasticity enhancement, wrinkle management, and radiance imparting.
본 발명에 따른 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 스프레이 및 이들의 혼합물로 구성된 군으로부터 선택되는 제형으로 제형화될 수 있다. The cosmetic composition according to the present invention can be used as a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing agent, oil, powder foundation, emulsion foundation, wax foundation, spray, and mixtures thereof. It may be formulated in a dosage form selected from the group consisting of:
본 발명에 따른 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 본 발명의 <3-8>의 혼합물이 화장료 조성물로 사용될 때에는 화장수, 에멀젼, 크림, 에센스, 젤, 팩 및 클렌징크림으로부터 선택되는 기초 화장료; 화운데이션 등의 메이크업 화장료로 구성되는 군으로부터 선택되는 제형으로 제조될 수 있다.The cosmetic composition according to the present invention can be prepared in any formulation commonly prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing It can be formulated as cleansing, oil, powder foundation, emulsion foundation, wax foundation, and spray, but is not limited to this. More specifically, when the mixture of <3-8> of the present invention is used as a cosmetic composition, it includes basic cosmetics selected from lotions, emulsions, creams, essences, gels, packs, and cleansing creams; It can be manufactured in a formulation selected from the group consisting of makeup cosmetics such as foundation.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier ingredient. You can.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder can be used as the carrier ingredient. In particular, when the formulation is a spray, chlorofluorohydrocarbon and propane may be used as carrier ingredients. /May contain propellants such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizing agent, or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 , 3-butyl glycol oil, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, the carrier ingredients include water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester, and microcrystals. Cellulose, aluminum metahydroxide, bentonite, agar, or tracant may be used.
본 발명의 제형이 계면활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing agent, the carrier ingredients include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, and fatty acid amide ether. Sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters may be used.
또한 본 발명의 화장료 조성물은 각각의 제형에 상기 기재한 성분들 이외에 일반 피부화장료에 배합되는 유분, 물, 계면활성제, 보습제, 저급알코올, 증점제, 킬레이트제, 색소, 방부제, 또는 향료 등을 필요에 따라 적절히 배합하여 사용할 수 있다.In addition, the cosmetic composition of the present invention contains oil, water, surfactant, moisturizer, lower alcohol, thickener, chelating agent, colorant, preservative, or fragrance mixed in general skin cosmetics in addition to the ingredients described above in each formulation. It can be used by mixing appropriately.
예컨대, 유연화장수는 본 발명의 <3-8>의 혼합물 이외에 다가알콜류(프로필렌글리콜, 글리세린 등) 1~10 중량% 및 계면활성제(폴리에틸렌올레일에테르, 폴리옥시에틸렌 경화피마자유 등) 0.05~2 중량%를 함유하도록 제조할 수 있다. 또한, 영양화장수 및 영양크림은 본 발명의 <3-8>의 혼합물 이외에 오일류(스쿠알란, 바셀린, 옥틸도데칸올 등) 5~20 중량% 및 왁스성분(세탄올, 스테아릴알콜, 밀납 등) 3~15 중량%를 함유하도록 제조할 수 있으며, 에센스는 본 발명의 <3-8>의 혼합물 이외에 글리세린, 프로필렌글리콜 등의 다가알콜류 5~30 중량%를 함유하여 제조할 수 있다. 마사지 크림은 본 발명의 <3-8>의 혼합물 이외에 유동파라핀, 바셀린, 이소노닐이소노나노에이트 등의 오일 30~70 중량%를 함유하여 제조되며, 팩은 본 발명의 <3-8>의 혼합물 이외에 폴리비닐알콜 5~20 중량%를 함유하는 필 오프(peel off) 팩 또는 일반유화형 화장료에 본 발명의 <3-8>의 혼합물 이외에 카올린, 탈크, 산화아연, 이산화티탄 등의 안료가 5~30 중량% 함유된 워시오프(wash off) 팩으로 제조할 수 있다.For example, in addition to the mixture of <3-8> of the present invention, the softening lotion contains 1 to 10% by weight of polyhydric alcohols (propylene glycol, glycerin, etc.) and 0.05 to 2% by weight of surfactants (polyethylene oleyl ether, polyoxyethylene hydrogenated castor oil, etc.) It can be manufactured to contain % by weight. In addition, nutritional lotion and nourishing cream contain 5 to 20% by weight of oils (squalane, petrolatum, octyldodecanol, etc.) and wax components (cetanol, stearyl alcohol, beeswax, etc.) in addition to the mixture of <3-8> of the present invention. It can be prepared to contain 3 to 15% by weight, and the essence can be prepared to contain 5 to 30% by weight of polyhydric alcohols such as glycerin and propylene glycol in addition to the mixture of <3-8> of the present invention. The massage cream is manufactured by containing 30 to 70% by weight of oils such as liquid paraffin, petroleum jelly, and isononyl isononanoate in addition to the mixture of <3-8> of the present invention, and the pack is made of the mixture of <3-8> of the present invention. In addition to the mixture, pigments such as kaolin, talc, zinc oxide, titanium dioxide, etc. in addition to the mixture of <3-8> of the present invention in a peel-off pack or general emulsion type cosmetic containing 5 to 20% by weight of polyvinyl alcohol. It can be manufactured as a wash off pack containing 5 to 30% by weight.
이하 본 발명을 실시예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail through examples and experimental examples.
단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 한정되는 것은 아니다.However, the following examples and experimental examples only illustrate the present invention, and the content of the present invention is not limited to the following examples and experimental examples.
<실시예 1> 식물 추출물의 제조<Example 1> Preparation of plant extract
하기 [표 1]에 개시된 각각의 원물 50 g에 16배량의 물을 가하여 12시간 동안 95℃에서 열수 추출한 후 여지(Watman grade 2, UK)로 여과한 뒤 농축기(EYELA N-3000, Japan)로 50℃에서 감압농축 및 동결건조 하여 열수 추출을 수득하였다.16 times the amount of water was added to 50 g of each of the raw materials shown in [Table 1] below, subjected to hot water extraction at 95°C for 12 hours, filtered through filter paper (Watman grade 2, UK), and then concentrated using a concentrator (EYELA N-3000, Japan). Hot water extraction was obtained by concentration under reduced pressure and freeze-drying at 50°C.
<실시예 2> 흑효모 발효물의 제조<Example 2> Preparation of black yeast fermentation product
미생물자원센터에서 흑효모균사체(A. pullulans var. melanogenum, KCTC No. 6081)를 분양받았다. 이 균체 배양을 위해, YM broth(Difco, France)와 정제수를 투입하여 배지를 제조하였다. 이 배지에 흑효모균사체를 접종한 후, 진탕 배양기(VS-8480, Vision, Korea)에서 48 시간 동안 발효를 시켰다. 이 발효액을 원심분리 후, 얻은 여과액을 동결 건조하여 최종 파우더 0.64 g을 수득하였다.Black yeast mycelium ( A. pullulans var. melanogenum , KCTC No. 6081) was purchased from the Microbial Resource Center. For culturing these bacteria, a medium was prepared by adding YM broth (Difco, France) and purified water. After inoculating black yeast mycelium into this medium, it was fermented for 48 hours in a shaking incubator (VS-8480, Vision, Korea). After centrifuging this fermentation broth, the obtained filtrate was freeze-dried to obtain 0.64 g of final powder.
<실시예 3> EGF(Epidermal Growth Factor) 및/또는 hGH(human growth hormone)를 함유하는 혼합물의 제조<Example 3> Preparation of a mixture containing Epidermal Growth Factor (EGF) and/or human growth hormone (hGH)
<3-1> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물 및 EGF를 함유하는 혼합물의 제조<3-1> Preparation of a mixture containing impatiens flower extract, wild rose extract, maca root extract and EGF
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물과 EGF를 포함하는 혼합물을 제조하였다.A mixture containing the impatiens flower extract, starling flower extract, maca root extract, and EGF prepared in <Example 1> was prepared.
구체적으로, 상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물을 각각 200 g 혼합한 후, 100 g의 EGF(Liquid)를 혼합하여, 혼합물을 제조하였다.Specifically, 200 g each of the impatiens flower extract, starling flower extract, and maca root extract prepared in <Example 1> were mixed, and then 100 g of EGF (Liquid) was mixed to prepare a mixture.
<3-2> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, EGF 및 hGH를 함유하는 혼합물의 제조<3-2> Preparation of a mixture containing impatiens flower extract, wild rose extract, maca root extract, EGF and hGH
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물을 각각 200 g 혼합한 후, 100 g의 EGF, 1 kg의 hGH(Liquid)를 혼합하여 혼합물을 제조하였다.A mixture was prepared by mixing 200 g each of the impatiens flower extract, wild rose extract, and maca root extract prepared in <Example 1>, followed by mixing 100 g of EGF and 1 kg of hGH (Liquid).
<3-3> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물 및 EGF를 함유하는 혼합물의 제조<3-3> Preparation of a mixture containing impatiens flower extract, starling flower extract, maca root extract, loquat tree leaf extract and EGF
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물을 각각 200 g 혼합한 후, 100 g의 EGF를 혼합하여, 혼합물을 제조하였다.Balsam flower extract prepared in <Example 1> above, A mixture was prepared by mixing 200 g of each of the wild rose extract, maca root extract, and loquat leaf extract and then mixing 100 g of EGF.
<3-4> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, EGF 및 hGH를 함유하는 혼합물의 제조<3-4> Preparation of a mixture containing impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, EGF and hGH
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물을 각각 200 g 혼합한 후, 100 g의 EGF, 1 kg의 hGH를 혼합하여 혼합물을 제조하였다.Balsam flower extract prepared in <Example 1> above, A mixture was prepared by mixing 200 g each of wild rose extract, maca root extract, and loquat leaf extract, followed by mixing 100 g of EGF and 1 kg of hGH.
<3-5> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물 및 EGF를 함유하는 혼합물의 제조<3-5> Preparation of a mixture containing impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, jicama root extract and EGF
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물을 각각 200 g 혼합한 후, 100 g의 EGF를 혼합하여, 혼합물을 제조하였다.A mixture was prepared by mixing 200 g of each of the impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, and jicama root extract prepared in <Example 1>, and then mixing 100 g of EGF.
<3-6> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물, EGF 및 hGH를 함유하는 혼합물의 제조<3-6> Preparation of a mixture containing impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, jicama root extract, EGF and hGH
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물을 각각 200 g 혼합한 후, 100 g의 EGF, 1 kg의 hGH를 혼합하여 혼합물을 제조하였다.After mixing 200 g each of the impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, and jicama root extract prepared in <Example 1>, 100 g of EGF and 1 kg of hGH were mixed to form a mixture. was manufactured.
<3-7> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물, 흑효모 발효물 및 EGF를 함유하는 혼합물의 제조<3-7> Preparation of a mixture containing impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, jicama root extract, black yeast fermentation product, and EGF
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물을 각각 200 g 혼합한 후, 상기 <실시예 2>에서 제조한 흑효모 발효물 200 g, 100 g의 EGF를 혼합하여, 혼합물을 제조하였다.After mixing 200 g each of the impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, and jicama root extract prepared in <Example 1>, the black yeast fermentation product prepared in <Example 2> was mixed. A mixture was prepared by mixing 200 g and 100 g of EGF.
<3-8> 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물, 흑효모 발효물, EGF 및 hGH를 함유하는 혼합물의 제조<3-8> Preparation of a mixture containing impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, jicama root extract, black yeast fermentation product, EGF and hGH
상기 <실시예 1>에서 제조한 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물을 각각 200 g 혼합한 후, 상기 <실시예 2>에서 제조한 흑효모 발효물 200 g, 100 g의 EGF, 1 kg의 hGH를 혼합하여 혼합물을 제조하였다.After mixing 200 g each of the impatiens flower extract, wild rose extract, maca root extract, loquat tree leaf extract, and jicama root extract prepared in <Example 1>, the black yeast fermentation product prepared in <Example 2> was mixed. A mixture was prepared by mixing 200 g, 100 g of EGF, and 1 kg of hGH.
<실시예 4> 크림 제형의 제조<Example 4> Preparation of cream formulation
상기 실시예 <3-1>을 이용하여 크림 제형을 제조하였으며, 크림 제형은 하기 [표 2]의 성분 및 함량으로 하여 제조하였다. 또한, 비교군으로는 100 g의 EGF, 1 kg의 hGH를 혼합한 혼합물을 이용하여 [표 2]의 성분 및 함량으로 비교군 크림 제형을 제조하였다.A cream formulation was prepared using Example <3-1>, and the cream formulation was prepared using the ingredients and contents shown in [Table 2] below. In addition, as a comparison group, a cream formulation of the comparison group was prepared using a mixture of 100 g of EGF and 1 kg of hGH with the ingredients and contents shown in [Table 2].
아울러, 상기 동일한 방법으로, 실시예 <3-2> 내지 <3-8>의 혼합물을 이용하여 크림제형을 제조하였다.In addition, a cream formulation was prepared using the mixture of Examples <3-2> to <3-8> using the same method as above.
<실험예 1> 주름 개선 및 탄력 증진 효과 확인<Experimental Example 1> Confirmation of wrinkle improvement and elasticity enhancement effect
상기 <실시예 4>에서 제조한 실시예 <3-1> 내지 <3-8>의 혼합물을 포함하는 크림 제형의 주름 개선 및 탄력 증진 효과를 확인하였다. The wrinkle improvement and elasticity enhancement effects of the cream formulation containing the mixture of Examples <3-1> to <3-8> prepared in <Example 4> were confirmed.
구체적으로, 30세 이후의 여성 90명을 9 그룹으로 각각 분류한 뒤, 세안 후 물기를 제거한 다음, 상기 <실시예 4>에서 제조한 실시예 <3-1> 내지 <3-8>의 혼합물을 포함하는 크림 제형, 및 대조군 크림 제형을 하루에 2회 15일간 얼굴에 골고루 분배하여 바르게 하였다. Specifically, 90 women over the age of 30 were classified into 9 groups, washed and dried, and then mixed with the mixture of Examples <3-1> to <3-8> prepared in <Example 4>. The cream formulation containing and the control cream formulation were evenly distributed and applied to the face twice a day for 15 days.
그런 다음, 주름 개선 및 탄력 증진 효과를 확인하기 위하여 평가는 7점 척도법을 사용하였고, 주름 개선 및 탄력 증진 효과는 점수가 높아질수록 선호도가 높은 것으로 설정하였다.Then, to confirm the wrinkle improvement and elasticity enhancement effect, a 7-point scale was used for evaluation, and the wrinkle improvement and elasticity enhancement effect was set to be more preferred as the score increased.
그 결과 표 3에 나타낸 바와 같이, 봉선화 꽃 추출물, 찔레꽃 추출물, 마카뿌리 추출물, 비파나무 잎 추출물, 히카마 뿌리 추출물, 흑효모 발효물, EGF 및 hGH을 필수적으로 포함하는 혼합물은 성분들의 상호작용을 통해 빠른 시간 내에 현저한 주름 개선 및 탄력 증진 효과를 나타냄을 확인하였다.As a result, as shown in Table 3, the mixture essentially containing impatiens flower extract, wild rose extract, maca root extract, loquat leaf extract, jicama root extract, black yeast fermentation product, EGF, and hGH showed no interaction of ingredients. It was confirmed that it showed significant wrinkle improvement and elasticity enhancement effects in a short period of time.
구체적으로, EGF와 hGH를 함께 사용할 경우, 전반적으로 EGF만을 사용한 군과 비교하여 우수한 효과를 나타내었으며, 특히 5종의 식물 추출물과 흑효모 발효물을 모두 포함할 경우, 상승적 효과로 인하여 현저한 피부 개선 효과를 나타냄을 확인하였다.Specifically, when EGF and hGH are used together, an overall superior effect was shown compared to the group using only EGF. In particular, when all five plant extracts and black yeast fermentation were included, the synergistic effect resulted in significant skin improvement. It was confirmed that it was effective.
따라서, EGF와 hGH를 상기 식물 추출물과 혼합하여 화장품 용도로 사용할 경우, 우수한 피부 개선 효과를 나타냄을 확인하였다(표 3). Therefore, it was confirmed that when EGF and hGH were mixed with the above plant extract and used for cosmetic purposes, it showed excellent skin improvement effect (Table 3).
<제조예 1> EGF와 hGH를 포함하는 Ampoul 제형의 제조<Preparation Example 1> Preparation of Ampoul formulation containing EGF and hGH
1 ppm의 EGF 와 10 ppm의 hGH를 포함하는 Ampoul 제형을 하기 [표 4]의 성분 및 함량을 이용하여 제조하였다.An Ampoul formulation containing 1 ppm of EGF and 10 ppm of hGH was prepared using the ingredients and contents shown in Table 4 below.
Claims (5)
A cosmetic composition for skin improvement containing EGF (Epidermal Growth Factor) as an active ingredient.
The cosmetic composition for skin improvement according to claim 1, wherein the EGF is contained in an amount of 0.5 to 2 ppm based on the total weight of the composition.
The method of claim 3, wherein the plant extract is Impatiens balsamina Flower Extract, Rosa multiflora Fruit Extract, Lepidium meyenii Root Extract, Eriobotrya japonica Leaf Extract, and A cosmetic composition for improving skin, characterized in that it contains at least one selected from the group consisting of jicama root extract ( Pachyrhizus erosus Root Extract).
The cosmetic composition for skin improvement according to claim 4, wherein the extract is extracted with water, C 1 to C 2 lower alcohol, or a mixed solvent thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220052581A KR20230152972A (en) | 2022-04-28 | 2022-04-28 | Functional cosmetic composition containing EGF as an active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220052581A KR20230152972A (en) | 2022-04-28 | 2022-04-28 | Functional cosmetic composition containing EGF as an active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230152972A true KR20230152972A (en) | 2023-11-06 |
Family
ID=88748644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220052581A KR20230152972A (en) | 2022-04-28 | 2022-04-28 | Functional cosmetic composition containing EGF as an active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230152972A (en) |
-
2022
- 2022-04-28 KR KR1020220052581A patent/KR20230152972A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101393007B1 (en) | Cosmetic Composition for Skin-aging Protection and Wrinkle Improvement Comprising the Extract of Nephelium lappaceum and Litchi chinensis sonn as Active Ingredient | |
KR101663946B1 (en) | Cosmetic composition containing an ginsenoside Rg3 reinforced extract of fermentative Ginseng flower(Panax ginseng C. A. Meyer) by Aureobasidium pullulans | |
KR101885195B1 (en) | Cosmetic Composition with Fermentative Extract of Osmanthus fragrans | |
KR20130028548A (en) | Cosmetic composition for skin cell regeneration, anti-inflammation and skin calming effect, and preparing method thereof | |
KR101749690B1 (en) | Cosmetic composition for sebum control and pore minimizing containing Wrinkled Giant Hyssop. | |
KR20150099457A (en) | Cosmetic composition comprising fermented Phellinus linteus extract | |
KR101855207B1 (en) | Cosmetic composition containing fermentative extract of terminalia ferdinandiana with increased amount of vitamin c fermented by aureobasidium pullulans | |
KR101981016B1 (en) | Functional moisturizing, antioxidant and wrinkle-improving functional cosmetic composition and preparing method thereof | |
KR102130243B1 (en) | A cosmetic composition for skin whitening, anti-wrinkle, anti-aging, and anti-oxidation containing glutathione, natural spicule powder, acetyl hexapeptide and broussonetia kazinoki extract | |
KR102077708B1 (en) | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component | |
KR102445830B1 (en) | Cosmetic Compositions for Skin Moisture Comprising Extract of Triticum aestivum | |
KR101953676B1 (en) | Cosmetic composition for skin moisturizing containing ultrasonicating extract of harpagophytum procumbens | |
KR102381273B1 (en) | Cosmetic composition with promoting collagen synthesis and shirinking skin-pores, and Manufacturing method thereof | |
KR20200064599A (en) | A cosmetic composition for skin improvement comprising EGF and hGH as active ingredients | |
KR102291780B1 (en) | Functional cosmetic composition for preventing skin aging and healing wounds containing natural substances and method for manufacturing the same | |
KR101843976B1 (en) | Cosmetic composition comprising extract of geminated phaseolus radiatus fermented by aureobasidium pullulans | |
KR20190049067A (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR20190021114A (en) | Composition for anti-inflammation, inhibiting secretion of sebum, or treating acne on the skin comprising plant extract | |
KR20230152972A (en) | Functional cosmetic composition containing EGF as an active ingredient | |
KR102107193B1 (en) | Cosmetic composition comprising extract of calendula arvensis fermented by aureobasidium pullulans | |
KR102018512B1 (en) | Cosmetic composition comprising extract of saliva miltiorrhiza fermented by aureobasidium pullulans | |
KR102121457B1 (en) | Cosmetic composition comprising the extract of fermented Sophora Japonica Fruits for skin anti-wrinkle effect and producing method thereof | |
KR102119622B1 (en) | Cosmetic composition comprising the extract of fermented Sorghum Bicolor sprout for skin anti-wrinkle effect and producing method thereof | |
KR20220141191A (en) | Composition for Skin Whitening, Moisturizing, Strengthening Skin Barrier, Skin Cell Regeneration, and Anti-Wrinkle Property Comprising Fermented Extract of Broussonetia kazinoki as Active Ingredient | |
KR101948657B1 (en) | Cosmetic composition for moisturizing skin containing ultrasonicating extract of dryopteris atrata |